en

PRODUCT DETAIL

Jansitin 50 mg filmom obalené tablety

Code 0532E
MA number 18/0102/22-S
Product Form: tbl flm 100x50 mg (fľ.HDPE)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH01 Sitagliptin
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 29.04.2022
Validity: 29.04.2027
SPC: SPC_Jansitin_04 2022.pdf  
PIL: PIL_Jansitin_04 2022.pdf  
Safety feature Yes
Data update: 04.05.2022
eu-flag.png sk-flag.png